PerkinElmer, Inc.
Apr 5, 2013
PDF

PerkinElmer to Present Translating Data into Clinical Medicine at the Bio-IT World Conference

WALTHAM, Mass.--(BUSINESS WIRE)-- PerkinElmer, Inc. (NYSE:PKI), a global leader focused on improving the health and safety of people and the environment, today announced that the Company will present at the Bio-IT World Conference at 11:00AM eastern time on Wednesday, April 10, 2013 at the Seaport World Trade Center located at 200 Seaport Boulevard in Boston, MA.

Kevin Hrusovsky, president of PerkinElmer's Life Sciences &Technology business, will be a featured speaker at the Bio-IT World Conference's Cancer Informatics track. In his Tools for Revolutionizing Translational Cancer Medicine presentation, Mr. Hrusovsky will discuss how combining the "in vitro-to-in vivo-to human" continuum of research tools with a powerful informatics platform may successfully bridge the chasm from laboratory research to clinical applications, particularly in the field of cancer medicine and personalized health.

For more information, visit the Bio-IT World Conference website.

About PerkinElmer

PerkinElmer, Inc. is a global leader focused on improving the health and safety of people and the environment. The company reported revenue of approximately $2.1 billion in 2012, has about 7,500 employees serving customers in more than 150 countries, and is a component of the S&P 500 Index. Additional information is available through 1-877-PKI-NYSE, or at www.perkinelmer.com.

Edelman (on behalf of PerkinElmer)
Paul Barren, 404-460-9679
Paul.barren@edelman.com

Source: PerkinElmer, Inc.

News Provided by Acquire Media